Behind the new kind of cell therapy that just won FDA approval
BioPharma
Stay updated with breaking news from Instil Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Instil Bio (NASDAQ: ) just reported results for the third quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate…
Instil Bio (NASDAQ: ) just reported results for the second quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Instil Bio (NASDAQ: ) just reported results for the first quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate…
By Stephen Nakrosis Shares of Instil Bio were trading below previous 52-week lows in Tuesday's after-hours market, following news the biopharmaceutical...